Chronic Myeloid Leukemia News

Chronic Myeloid Leukemia News

The Twitter Effect on How Oncologists Conduct and Share Research

Publish Date August 12, 2020

The social media platform can be useful as an education tool for oncologists to stay up to date on new research in oncology — but physicians still need to be mindful of the information sources.

How Patients Lose Their Own Voices: Disparities in Patient-Reported Outcome Capture in Clinical Trials

Publish Date August 7, 2020

It remains important to interrogate how structural discrimination influences the collection of patient-reported outcomes.

Researchers Reveal Racial Disparities in Access to Remdesivir for Patients With Cancer and COVID-19

Publish Date July 24, 2020

Black patients were half as likely to receive remdesivir as White patients, according to researchers from the CCC19.

Conflicts of Interest Continue to Plague Oncology Guidelines and Research

Publish Date July 15, 2020

New research presented at ASCO 2020 sheds light on conflicts of interest among NCCN panelists and links industry dollars to measures of academic success among junior faculty.

Why Cancer Centers May Need to Rethink the Hard Sell to Patients

Publish Date July 14, 2020

Two recent papers are encouraging cancer center executives to rethink how they position their services to potential patients.

Study Provides Support for TKI Discontinuation in Some Patients With CML

Publish Date June 12, 2020

This population-based study of patients with chronic phase CML evaluated the BCR/ABL1 TKI discontinuation rates for patients treated on and off a clinical trial.

Has the Time for At-Home Cancer Care Finally Come?

Publish Date June 10, 2020

A Penn Medicine team debuts its program focused on cancer care at home — just in time for COVID-19.

Genomics Industry Tries New Strategies to Engage Community Oncologists

Publish Date May 21, 2020

Streamlined prescribing and reimbursement, patient education tools aim to overcome barriers to adoption of genetic testing.

A New Look at the Dose-Response Relationship in Phase 1 Oncology Trials

Publish Date May 13, 2020

The new generation of cancer drugs behave quite differently than cytotoxic therapies, and that may mean phase 1 trials need to be updated.

Researchers Turn to Crowdsourcing to Learn More About COVID-19 and Cancer

Publish Date May 7, 2020

Pooling data from physicians and patients appears to be an efficient way to answer urgent questions.

Early Monitoring of Chronic Myeloid Leukemia Might Dictate TKI Switch

Publish Date April 20, 2020

Lack of initial response to imatinib might indicate need to switch to dasatinib.

Not Developing Any New Drugs Could Be EQRx’s Biggest Innovation

Publish Date March 24, 2020

The best bet for a new company hoping to deliver on a lofty promise to “remake medicine” could rely on drug repurposing.

“Medical Distancing” May Help Protect Cancer Patients From Exposure to COVID-19

Publish Date March 17, 2020

Screening patients by phone before they come to a clinic may help to eliminate potentially redundant visits and lower the risk of infection.

Federal Ruling Puts Pressure on Clinical Trial Sponsors to Post Data

Publish Date March 11, 2020

A federal ruling will force trial sponsors to post basic results on ClinicalTrials.gov, but it is unclear whether this is a feasible mandate.

First Human Clinical Trial in US to Test the Use of CRISPR-Modified T Cells in Cancer Answers Vital Questions

Publish Date March 5, 2020

CRISPR-modified T cells were used in 3 patients with advanced cancer for the first time, showing modest results on tumor growth.

Improving Cancer Pain Management Amid the Opioid Crisis

Publish Date March 3, 2020

Research into opioid alternatives for cancer-related pain has stalled, however substance use disorders remain problematic.

A New Trend in Drug Development: Leveraging Data from Expanded Access

Publish Date March 2, 2020

Drug companies are gathering and including expanded access data in drug submissions as real-world data, but the purpose of expanded access was never for the purpose of research.

The Questionable Practice That Permeates Oncology Clinical Trials

Publish Date February 19, 2020

Most oncology phase 1 trials use a simplistic, outdated dose-finding technique, and experts agree that change is needed.

Integrative Oncology: Using Evidence-Informed Medicine to Improve Patient Outcomes and Quality of Life

Publish Date February 13, 2020

Lifestyle-based integrative treatment approaches — deemed scientifically sound by the field’s proponents — merge conventional and complementary treatments.

Oral Oncology Parity Laws Don’t Make Medications More Affordable

Publish Date February 7, 2020

Out-of-pocket spending remains high for many patients with blood cancers who are receiving tyrosine kinase inhibitors and immunomodulatory drugs.